Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2021
Matchpoint Therapeutics is a biotechnology company focused on discovering precision small molecule medicines that utilize covalency to treat immune diseases. Their Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and a proprietary library of covalent compounds to identify and develop novel therapeutics. The company differentiates itself through its ability to target previously unamenable proteins, offering increased potency and selectivity in drug development. With a commitment to sustainability and a strong leadership team, Matchpoint is positioned to make a significant impact in the biotechnology sector.
Something looks off?